Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.67B | 11.80B | 11.27B | 12.50B | 12.41B | 12.97B |
Gross Profit | 4.51B | 4.54B | 4.09B | 4.99B | 5.31B | 5.36B |
EBITDA | 1.71B | 1.76B | 1.38B | 2.11B | 2.68B | 2.87B |
Net Income | 514.10M | 550.86M | 298.28M | 873.06M | 1.31B | 1.55B |
Balance Sheet | ||||||
Total Assets | 13.17B | 13.19B | 12.50B | 12.96B | 12.44B | 11.83B |
Cash, Cash Equivalents and Short-Term Investments | 7.32B | 4.43B | 4.06B | 5.05B | 7.29B | 6.53B |
Total Debt | 5.00M | 59.38M | 108.39M | 172.74M | 211.28M | 321.93M |
Total Liabilities | 2.17B | 2.13B | 1.63B | 2.03B | 2.07B | 2.67B |
Stockholders Equity | 10.52B | 10.56B | 10.41B | 10.51B | 10.01B | 8.87B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.97B | -29.23M | 1.16B | 1.18B | 1.62B |
Operating Cash Flow | 0.00 | 2.09B | 812.01M | 1.80B | 1.85B | 2.07B |
Investing Cash Flow | 0.00 | -617.28M | -1.31B | -747.07M | -784.22M | -774.50M |
Financing Cash Flow | 0.00 | -500.16M | -492.92M | -495.90M | -301.54M | 3.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥9.25B | 16.79 | 3.76% | 4.74% | 84.68% | ||
74 Outperform | ¥13.50B | 40.20 | 2.15% | 9.55% | -49.89% | ||
72 Outperform | ¥6.49B | 8.38 | 3.34% | -6.82% | -4.67% | ||
68 Neutral | ¥12.98B | 20.68 | 0.89% | -4.12% | 115.46% | ||
65 Neutral | ¥2.97B | 15.05 | ― | -20.82% | ― | ||
61 Neutral | $40.69B | -0.79 | -11.97% | 3.78% | 2.11% | -69.16% | |
47 Neutral | ¥6.14B | ― | ― | 16.03% | -27.98% |